MARKET

ALKS

ALKS

Alkermes Plc
NASDAQ
24.18
+0.21
+0.88%
Opening 11:38 11/29 EST
OPEN
24.00
PREV CLOSE
23.97
HIGH
24.33
LOW
23.71
VOLUME
172.90K
TURNOVER
2.44M
52 WEEK HIGH
32.79
52 WEEK LOW
21.24
MARKET CAP
3.97B
P/E (TTM)
-30.6503
1D
5D
1M
3M
1Y
5Y
Alkermes Supporting Local Communities
Alkermes respects the culture, customs and values of the people in the communities in which we operate.
ACCESSWIRE · 1d ago
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Investor's Business Daily · 6d ago
How Alkermes (ALKS) Stock Stands Out in a Strong Industry
Alkermes (ALKS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks · 6d ago
Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Tuesday, Nov. 29, 2022 at 2:40 p.m. ET (7:40 p.m. GMT). The live webcast may be accessed under the Inves...
PR Newswire · 11/22 21:00
Equal Opportunity and Respect at Alkermes
At Alkermes, we strive to foster a culture of respect, inclusion and equality, supported by our Code of Business Conduct and Ethics and our other corporate policies and programs.
ACCESSWIRE · 11/22 17:10
Mizuho Maintains Buy on Alkermes, Raises Price Target to $36
Benzinga · 11/22 12:53
Mizuho Adjusts Price Target on Alkermes to $36 From $34, Maintains Buy Rating
Mizuho Adjusts Price Target on Alkermes to $36 From $34, Maintains Buy Rating
MT Newswires · 11/22 09:44
10 Tips for Caring for the Family Caregiver
National Family Caregivers Month begins today. Supporting a loved one with a serious mental illness is important, but it is also critical for caregivers to make time to prioritize their own wellbeing.
ACCESSWIRE · 11/21 16:30
More
About ALKS
Alkermes Public Limited Company is a fully integrated biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. It has a portfolio of commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. The Company's products include ALKERMES, ARISTADA, ARISTADA INITIO, LinkeRx, LYBALVI, NanoCrystal and VIVITROL. Its other trademark includes INVEGA SUSTENNA, INVEGA TRINZA, TREVICTA, XEPLION, and RISPERDAL CONSTA, KEYTRUDA and VUMERITY. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.

Webull offers kinds of Alkermes Plc stock information, including NASDAQ:ALKS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALKS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ALKS stock methods without spending real money on the virtual paper trading platform.